Study Reveals How BRCA1-A Complex Recognizes and Cleaves Ubiquitin Chains at DNA Damage Sites
Scientists have determined the molecular mechanism by which the BRCA1-A super-complex recognizes and cleaves K63-linked polyubiquitin chains at sites of DNA damage. The ARISC-RAP80 component uses a composite three-subunit interface and multiple ubiquitin-binding sites to position and compact these chains for catalytic cleavage, a mechanism distinct from other known deubiquitylases. Understanding this process clarifies how BRCA1-A coordinates DNA damage responses, with potential implications for cancer biology given BRCA1's established role in tumor suppression.
A new study published on bioRxiv describes the structural and mechanistic basis by which the BRCA1-A super-complex decodes and cleaves K63-linked polyubiquitin chains at DNA damage sites. The ARISC-RAP80 sub-complex, which partners with BRCA1-BARD1, was found to use a composite interface formed by three subunits to position polyubiquitin chains within its catalytic site. Additional ubiquitin-binding sites on RAP80 and non-catalytic regions impose a compact conformation on the substrate chains, exploiting the inherent flexibility of long ubiquitin polymers. This mechanism is notably different from those used by other deubiquitylases, suggesting a specialized evolutionary adaptation for DNA damage signaling. Structure-guided mutagenesis experiments validated the key ubiquitin chain interaction sites, and cell-based assays confirmed that these interfaces are functionally required for proper chromatin recruitment. The findings integrate ubiquitin 'reading' and 'erasing' functions within a single complex, offering a more complete picture of how BRCA1-A orchestrates the cellular response to DNA damage.
What's missing
As a preprint, this study has not yet undergone formal peer review, so findings should be considered preliminary. The study does not address whether mutations in these newly identified interfaces are found in cancer patients, nor does it explore therapeutic implications of disrupting or enhancing this mechanism. The in vivo relevance of the compact ubiquitin chain conformation beyond cell-based assays remains to be established.
What different sources said
- bioRxivCenter
Mechanism of K63-linked polyubiquitin recognition and cleavage by the BRCA1-A complex
Related
Gut Bacteria Enzyme Found to Break Down Heat-Processed Food Compounds, Producing Novel Biogenic Amines
Researchers have discovered that an enzyme in common gut bacteria can degrade N-epsilon-carboxymethyllysine (CML), a compound formed during thermal food processing, producing previously unknown biogenic amines. The enzyme, ornithine decarboxylase SpeC from enterobacteria, acts on CML and related modified lysine derivatives through a low-level 'underground' catalytic activity. This finding suggests a previously unrecognized communication axis between thermally processed dietary compounds and gut microbial physiology, with potential implications for host health.
Full-Length Gene Sequencing Reveals Two Distinct Bacterial Communities in Black-Legged Ticks Expanding Into Canada
Researchers used Oxford Nanopore full-length 16S rRNA gene sequencing to characterize the microbiome of Ixodes scapularis black-legged ticks collected in Nova Scotia, Canada, distinguishing between tick-adapted bacteria and environmentally acquired bacteria. The study comes as I. scapularis — the primary vector of Lyme disease — is rapidly expanding northward into Canada due to climate change. The findings suggest that environmentally derived bacteria in tick microbiomes are not mere contamination, which has implications for how tick microbiome data is collected and interpreted across surveillance studies.
Study Identifies Metabolic Link Between Cell Envelope Stress and Biofilm Formation in Bacteria
Researchers have discovered that the metabolite acetyl-CoA directly inhibits enzymes that degrade the bacterial signaling molecule c-di-GMP, connecting cell envelope biosynthesis stress to biofilm formation in Pseudomonas aeruginosa. The study found that sub-inhibitory concentrations of antibiotics targeting early peptidoglycan biosynthesis — but not other antibiotic classes — elevate c-di-GMP levels by reducing phosphodiesterase activity, with acetyl-CoA competing for the enzyme active site. Because the relevant enzyme domain is broadly conserved across bacterial species, this checkpoint mechanism may be widespread and could have implications for understanding antibiotic-induced biofilm responses.